Your session is about to expire
← Back to Search
Prednisone Taper for Rheumatoid Arthritis (SMART-RA Trial)
SMART-RA Trial Summary
This trial seeks to understand why people with RA have different responses to reducing steroid doses. It will look at inflammation, brain info processing and hormone levels.
SMART-RA Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSMART-RA Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.SMART-RA Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How many volunteers have enrolled in this clinical trial?
"Affirmative. Documents available on clinicaltrials.gov demonstrate that this research endeavour, which was initially put up for public view on March 9th 2023, is currently in search of participants. The trial hopes to enrol 200 patients from a single location."
Has the FDA authorized a 15-day tapering regimen of prednisone?
"15-day taper prednisone has been evaluated by our Power team with a rating of two, as the Phase 2 trial it is part of suggests there are some safety findings but no clinical efficacy."
Does this clinical trial have any available spots for participants?
"Affirmative. Clinicaltrials.gov data attests to that this clinical trial is still recruitment individuals, with it having first been posted on March 9th 2023 and updated most recently on October 2nd 2023. This study requires 200 participants from a single location for completion."
Who else is applying?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger